Companies: 10,795·Total market cap: $144.5T
InspireMD, Inc.

InspireMD, Inc.

NSPRNASDAQHealthcare● Active
$0.82
$-0.06(-7.24%)
Market Cap$38234676
P/E Ratio
52W High$2.93
52W Low$0.8
Overview

InspireMD, Inc. (NSPR) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nspr · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 85.7%

12-Month Price Target

High

$6.00

Consensus

$4.50

+451.3% upside

Low

$3.00

Median: $4.5 · Last Close: $0.82

The InspireMD, Inc. (NSPR) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month NSPR price target is $4.50, representing +451.3% upside from the current price of $0.82.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $5 (451.3%)

Consensus Target

$4.50

451.3% upside

High Target

$6

635.0%

Low Target

$3

267.5%

Current Price

$0.82

as of today

Based on analyst price targets, the NSPR stock price prediction for the next 12 months ranges from $3 to $6. The consensus NSPR price forecast of $4.50 implies 451.3% upside from the current price of $0.82.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$0.785.00%

1-day model range: $0.77–$0.78. Peak: $0.78 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$0-50.0%
2028$0-62.5%
2029$0-67.2%
2030$0-69.2%
2031-70.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%0%93%
1Buy
0Neutral
13Sell
RSI (14)28.9Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NSPR · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.92SELL
MA 10$0.92SELL
MA 20$1.01SELL
MA 50$1.20SELL
MA 100$1.45SELL
MA 200$1.80SELL
Current $NSPR · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.89SELL
EMA 10$0.93SELL
EMA 20$1.00SELL
EMA 50$1.18SELL
EMA 100$1.40SELL
EMA 200$1.70SELL
Current $NSPR · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Piper Sandler2026-05-05
Maintains
OverweightOverweight
Piper Sandler2025-05-12
Maintains
OverweightOverweight
Piper Sandler2023-11-02
Maintains
OverweightOverweight
Piper Sandler2023-06-12
Maintains
OverweightOverweight
National Alliance Securities2023-05-17
Maintains
BuyBuy
Alliance Global Partners2023-03-31
Maintains
BuyBuy
H.C. Wainwright2020-03-11
Maintains
BuyBuy
Rodman & Renshaw2016-03-29
Maintains
BuyBuy
H.C. Wainwright2016-01-07
Maintains
BuyBuy
Oppenheimer2015-03-13
Downgrade ↓
OutperformPerform

Wall Street analysts have recently issued updated ratings on InspireMD, Inc. (NSPR) stock. Of the recent 12 rating actions, 0 were upgrades and 1 were downgrades. 7 analysts currently cover NSPR.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

NSPR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$6M

↓ 23.3% YoY

Revenue Next Year

$7M

↑ 6.5% YoY

EPS This Year

$0.00

EPS Next Year

$-0.78

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NSPR EPS of $0.00 for the current fiscal year, based on estimates from 0 analysts. The NSPR revenue forecast is $6M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NSPR stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NSPR price target is $4.50 (+451.3% upside), with an analyst consensus of Buy.

The NSPR short-term stock prediction for tomorrow is $0.78 (-5.00%). The NSPR stock price prediction for 2027 estimates an average of $0. The NSPR stock prediction for 2030 projects a range of $0–$0.

InspireMD, Inc. trades on NASDAQ under the ticker NSPR. The NSPR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NSPR forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month NSPR price target is $4.50, with a high forecast of $6.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +451.3% potential upside from the current price of $0.82.

NSPR price targetWhat is NSPR price targetNSPR analyst price targetNSPR 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.